PHAXIAM Therapeutics S.A. Equity
PHAXIAM Therapeutics S.A. had Equity of EUR 36.63 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes
ifrs-full:Equity · last filed 2023-09-26
- 2023-06-30: Equity 36.63M EUR.
- 2022-12-31: Equity 23.49M EUR.
- 2022-06-30: Equity 22.44M EUR.
- 2021-12-31: Equity 22.84M EUR.
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2023-06-30 | 36.63M EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 23.49M EUR 6-K · filed 2023-09-26 | |
| 2022-06-30 | 22.44M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 22.84M EUR 6-K · filed 2023-09-26 | |
| 2021-06-30 | 36.36M EUR 6-K · filed 2022-09-12 | |
| 2020-12-31 | 26.54M EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 51.11M EUR 6-K · filed 2021-09-20 | 51.11M EUR 6-K · filed 2020-09-21 |
| 2019-12-31 | 85.56M EUR 20-F · filed 2023-03-28 | |
| 2019-06-30 | 117.03M EUR 6-K · filed 2020-09-21 | |
| 2018-12-31 | 145.60M EUR 20-F · filed 2022-04-27 | |
| 2018-06-30 | 163.81M EUR 6-K · filed 2019-09-26 | |
| 2017-12-31 | 181.42M EUR 20-F · filed 2021-03-08 | 181.42M EUR 20-F/A · filed 2018-05-23 |
| 2016-12-31 | 35.64M EUR 20-F · filed 2020-03-18 | |
| 2015-12-31 | 47.13M EUR 20-F · filed 2019-03-29 | 47.13M EUR 20-F/A · filed 2018-05-23 |